Phenacyl bromide → HCID 86688889, compound
Reaction equation
[CH3:1][CH:2]1[CH2:7][CH2:6][N:5]([CH:8]([C:20]2[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=2)[C:9]([O:11][C@@H:12]2[CH:17]3[CH2:18][CH2:19][N:14]([CH2:15][CH2:16]3)[CH2:13]2)=[O:10])[CH2:4][CH2:3]1.[Br:26][CH2:27][C:28]([C:30]1[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=1)=[O:29]>C(#N)C>[Br-:26].[CH3:1][CH:2]1[CH2:7][CH2:6][N:5]([CH:8]([C:20]2[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=2)[C:9]([O:11][C@@H:12]2[CH:17]3[CH2:18][CH2:19][N+:14]([CH2:27][C:28](=[O:29])[C:30]4[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=4)([CH2:15][CH2:16]3)[CH2:13]2)=[O:10])[CH2:4][CH2:3]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
(R)-Quinuclidin-3-yl 2-(4-methylpiperidin-1-yl)-2-phenylacetate (58 mg, 0.17 mmol) and 2-bromo-1-phenylethanone (37.1 mg, 0.19 mmol) were dissolved in acetonitrile (3 ml) and stirred at room temperature overnight. The solvent was evaporated and the residue was tritured with Et2O and filtered under vacuum. The recovered solid was further purified by preparative HPLC to obtain (3R)-3-(2-(4-methylpiperidin-1-yl)-2-phenylacetoxy)-1-(2-oxo-2-phenylethyl)-1-azoniabicyclo[2.2.2]octane bromide (5 mg, 5.5% yield) as a colorless oil.
Workup
- customThe solvent was evaporated
- filtrationfiltered under vacuum
- customThe recovered solid was further purified by preparative HPLC
Sources & evidence
- ORD record
- ord-bbf1caa97f5f48789df429c09b09bfe2
- Source dataset
- uspto-grants-2014_06
- Patent number
- US08748613B2
Reaction notes
Loading…